Pneumococcal Infections

  • Robert S. Baltimore
  • Eugene D. Shapiro


The pneumococcus (Streptococcus pneumoniae) is a major cause of pneumonia and meningitis worldwide. In his classic book entitled The Biology of the Pneumococcus published in 1938, Benjamin White(162) listed 19 different names applied to the pneumococcus between 1897 and 1930, the year when the 4th edition of Bergey’s Manual (15) approved the designation Diplococcus pneumoniae Weichselbaum. In a more recent (8th) edition of Bergey’s Manual, (26) it is listed as Streptococcus pneumoniae, the designation now generally accepted.


Otitis Medium Streptococcus Pneumoniae Minimum Inhibitory Concentration Pneumococcal Disease Pneumococcal Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ahonkhai, V. I., Landesman, S. H., Fikrig, S. M., Schmalzer, E. A., Brown, A. K. , Cherubin, C. E. , and Schiffman, G., Failure of pneumococcal vaccine in children with sickle-cell disease, N. Engl. J. Med. 301:26–27 (1979).PubMedGoogle Scholar
  2. 2.
    Ammann, A. J., Addiego, J., Wara, D. W., Lubin, B., Smith, W. B. , and Mentzer, W. C. , Polyvalent pneumococcal-polysaccharide immunization of patients with sickle-cell anemia and patients with splenectomy, N. Engl. J. Med. 297:897–900 (1977).PubMedGoogle Scholar
  3. 3.
    Ammann, A. J., Schiffman, G. , Addiego, J. E. , Wara, W. M., and Wara, D. W., Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccine, Rev. Infect. Dis. 3(Suppl.):S 160-S 167 (1981).Google Scholar
  4. 4.
    Applebaum, P. C., World-wide development of antibiotic resistance in pneumococci, Eur. J. Clin. Microbiol. 6:367–377 (1987).Google Scholar
  5. 5.
    Applebaum, P. C., Bhamjee, A. , Scragg, J. N. , Hallett, A. F., Bowen, A. J., and Cooper, R. C., Streptococcus pneumoniae resistant to penicillin and chloramphenicol, Lancet 2:995–997 (1977).Google Scholar
  6. 6.
    Armstrong, R. R. , A swift and simple method for deciding pneumococcal “type,” Br. Med. J. 1:214–215 (1931).PubMedGoogle Scholar
  7. 7.
    Austrian, R., Surveillance of pneumococcal infection for field trials of polyvalent pneumococcal vaccine, Report DAB-VDP- 12–84, pp. 1–84, National Institutes of Health, Bethesda, 1980.Google Scholar
  8. 8.
    Austrian, R. , Pneumococcus, the first hundred years, Rev. Infect. Dis. 3:183–189 (1981).PubMedGoogle Scholar
  9. 9.
    Austrian, R., Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention, Rev. Infect. Dis. 3(Suppl.):S1-S17 (1981).Google Scholar
  10. 10.
    Austrian, R. A reassessment of pneumococcal vaccine [Editorial], N. Engl. J. Med. 310:651–653 (1984).PubMedGoogle Scholar
  11. 11.
    Austrian, R., and Gold, J., Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia, Ann. Intern. Med. 60:759–776 (1964).PubMedGoogle Scholar
  12. 12.
    Austrian, R. , Douglas, R. M. , Schiffman, G., Coetzee, A. M., Koornhof, H. J., Hayden-Smith, S., and Reid, R. D. W. , Prevention of pneumococcal pneumonia by vaccination, Trans. Assoc. Am. Physicians 89:184–194 (1976).PubMedGoogle Scholar
  13. 13.
    Avery, O. T., Macleod, C. M., and Mccarty, M., Studies on the chemical nature of the substance inducing transformation of pneumococcal types: Induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type Iii, J. Exp. Med. 79:137–158 (1944).PubMedGoogle Scholar
  14. 14.
    Benjamin, J. E., Ruegsegger, J. M., and Senior, F. A., Cross-infection in pneumococcic pneumonia, J. Am. Med. Assoc. 112:1127–1130 (1939).Google Scholar
  15. 15.
    Bergey, D. H., A key to the identification of organisms of the class Schizomycetes, in: Bergey’s Manual of Determinative Bacteriology, 4th ed., p. 48, Williams & Wilkins, Baltimore, 1934.Google Scholar
  16. 16.
    Bernstein, L. J., Krieger, B. Z. , Novick, B. , Sicklick, M. J., and Rubinstein, A. , Bacterial infection in the acquired immunodeficiency syndrome of children, Pediatr. Infect. Dis. 4:472–475 (1985).PubMedGoogle Scholar
  17. 17.
    Bolan, G. , Broome, C. V. , Facklam, R. R. , Pilkaytis, B. D., Fraser, D. W., and Schlech, W. F., III, Pneumococcal vaccine efficacy in selected populations in the United States, Ann. Intern. Med. 104:1–6 (1986).PubMedGoogle Scholar
  18. 18.
    Borgono, J. M. , McLean, A. A. , Vella, P. P. , Woodhour, A. F., Canepa, I., Davidson, W. L., and Hilleman, M. R. ,Vaccination and revaccination with polyvalent pneumococcal polysaccharide vaccines in adults and infants, Proc. Soc. Exp. Biol. Med. 157:148–154 (1978).PubMedGoogle Scholar
  19. 19.
    Broome, C. V., Efficacy of pneumococcal polysaccharide vaccines, Rev. Infect. Dis. 3(Suppl.):S82-S83 (1981).Google Scholar
  20. 20.
    Broome, C. V., and Facklam, R. R., Epidemiology of clinically significant isolates of Streptococcus pneumoniae in the United States, Rev. Infect. Dis. 3:277–281 (1981).PubMedGoogle Scholar
  21. 21.
    Broome, C. V., Facklam, R. R., Allen, J. R., Fraser, D. W. , and Austrian, R. , Epidemiology of pneumococcal serotypes in the United States, 1978–79, J. Infect. Dis. 141:119–123 (1980).PubMedGoogle Scholar
  22. 22.
    Broome, C. V., Facklam, R. R., and Fraser, D. W., Pneumococcal disease after pneumococcal vaccination: An alternative method to estimate the efficacy of pneumococcal vaccine, N. Engl. J. Med. 303:549–552 (1980).PubMedGoogle Scholar
  23. 23.
    Brown, E. J., Hosea, S. W., and Frank, M. M., The role of antibody and complement in the reticuloendothelial clearance of pneumococci from the blood stream, Rev. Infect. Dis. 5:S797-S805 (1983).Google Scholar
  24. 24.
    Brown, J. W., and Finland, M., A family outbreak of type V pneumococcus infections: Clinical, bacteriological and immunological studies, Ann. Intern. Med. 13:394–401 (1939).Google Scholar
  25. 25.
    Brundage, D. K., Russell, A. E., Jones, R. R., Bloomfield, J. J., and Thompson, R., Frequency of pneumonia among iron and steel workers, Public Health Bulletin No. 202, U.S. Government Printing Office, Washington, D.C., 1932.Google Scholar
  26. 26.
    Buchanan, R. E., and Gibbons, W. E. (co-eds.), Bergey’s Manual of Determinative Bacteriology, 8th ed. , pp. 499–500, Williams & Wilkins, Baltimore, 1974.Google Scholar
  27. 27.
    Bullowa, J. G. M., The Management of the Pneumonias for Physicians and Medical Students, Oxford University Press, New York, 1937.Google Scholar
  28. 28.
    Burman, A., Norrby, R. , and Trollfors, B. , Invasive pneumococcal infections: Incidence, predisposing factors and prognosis, Rev. Infect. Dis. 7:133–142 (1985).PubMedGoogle Scholar
  29. 29.
    Calvelli, T. A. and Rubinstein, A., Intravenous gammaglobulin in infant acquired immunodeficiency syndrome, Pediatr. Infect. Dis. 5:S207-S210 (1986).Google Scholar
  30. 30.
    Centers for Disease Control, Surveillance summary: Bacterial meningitis and meningococcemia, Morbid. Mortal. Weekly Rep. 28:277–279 (1979).Google Scholar
  31. 31.
    Centers for Disease Control, Recommendations of the Immunization Practices Advisory Committee (ACIP): Pneumococcal polysaccharide vaccine, Morbid. Mortal. Weekly Rep. 30:410–419 (1981).Google Scholar
  32. 32.
    Centers for Disease Control, Recommendations of the Immunization Practices Advisory Committee (ACIP) update: Pneumococcal vaccine usage-United States, Morbid. Mortal. Weekly Rep. 33:273–281 (1984).Google Scholar
  33. 32a.
    Centers for Disease Control, Recommendations of the Immunization Practices Advisory Committee (ACIP): Pneumococcal polysaccharide vaccine, Morbid. Mortal. Weekly Rep. 38:64–76 (1989).Google Scholar
  34. 33.
    Clemens, J. D., and Shapiro, E. D., Resolving the pneumococcal vaccine controversy: Are there alternatives to randomized clinical trials? Rev. Infect. Dis. 6:589–600 (1984).PubMedGoogle Scholar
  35. 34.
    Cole, R., and Maccallum, W. G., Pneumonia at a base hospital, J. Am. Med. Assoc. 70:1146–1156 (1918).Google Scholar
  36. 35.
    Collins, S. D., and Gover, M. Age and seasonal incidence of minor respiratory attacks classified according to clinical symptoms, Am. J. Hyg. 20:533–554 (1934).Google Scholar
  37. 36.
    Committee on Infectious Diseases, American Academy of Pediatrics, Recommendations for using pneumococcal vaccine in children, Pediatrics 75:1153–1158 (1985).Google Scholar
  38. 37.
    Coonrod, J. D., and Yoneda, K., Complement and opsonins in alveolar secretions and serum of rats with pneumonia due to Streptococcus pneumoniae, Rev. Infect. Dis. 3:310–322 (1981).PubMedGoogle Scholar
  39. 38.
    Cooper, G. , Rosenstein, C., Walter, A., and Peizer, L. , The further separation of types among the pneumococci hitherto included in group Iv and the development of therapeutic antisera for these types, J. Exp. Med. 55:531–554 (1932).PubMedGoogle Scholar
  40. 39.
    Cruickshank, R. , Pneumococcal Infections (Milroy Lectures), Lancet 1:563–568, 621–626, 680–685 (1933).Google Scholar
  41. 40.
    Dajani, A. S. , Antibiotic-resistant pneumococci, Pediatr. Infect. Dis. 1:143–144 (1982).PubMedGoogle Scholar
  42. 41.
    Davies, J. A. V., The response of infants to inoculation with type 1 pneumococcus carbohydrate, J. Immunol. 33:1–7 (1937).Google Scholar
  43. 42.
    Dochez, A. R. , and Gillespie, L. J., A biological classification of pneumococci by means of immunity reactions, J. Am. Med. Assoc. 61:727–730 (1913).Google Scholar
  44. 43.
    Drinker, C. K., and Field, M. E., Lymphatics, Lymph and Tissue Fluid, Williams & Wilkins, Baltimore, 1933.Google Scholar
  45. 44.
    Ebgert, J. H. , Epidemic pneumonia in the tropics, N.Y. Med. J. 103:1125 (1916).Google Scholar
  46. 45.
    Ekwurzel, G. M., Simmons, J. S., Dublin, H., and Felton, L. D., Studies of immunizing substances in pneumococci. VIII. Report on field test to determine the prophylactic value of a pneumococcus antigen, Public Health Rep. 53:1877–1893 (1938).Google Scholar
  47. 46.
    Fedson, D. S., Improving the use of pneumococcal vaccine through a strategy of hospital-based immunization: A review of its rationale and implications, J. Am. Geriatr. Soc. 33:142–150 (1985).PubMedGoogle Scholar
  48. 47.
    Feldman, C., Kallenbach, J. M., Miller, S. D., Thorburn, J. R. , and Koornhof, H. , Community-acquired pneumonia due to penicillin-resistant pneumococci, N. Engl. J. Med. 313:615–617 (1985).PubMedGoogle Scholar
  49. 48.
    Felton, L. D., Studies on immunizing substances in pneumococci. Vii. Response in human beings to antigenic pneumococcus polysaccharides, type I and Ii, Public Health Rep. 53:2855–2877 (1938).Google Scholar
  50. 49.
    Finland, M. , Recent advances in the epidemiology of pneumococcal infections, Medicine 21:307–344 (1942).Google Scholar
  51. 50.
    Finland, M. , The present status of the higher types of antipneumococcus serums, J. Am. Med. Assoc. 120:1294–1307 (1942).Google Scholar
  52. 51.
    Finland, M., Pneumonia and pneumococcal infections, with special reference to pneumococcal pneumonia: The 1979 J. Burns Amberson Lecture, Am. Rev. Respir. Dis. 120:481–502 (1979).PubMedGoogle Scholar
  53. 52.
    Finland, M. , and Barnes, M. W. , Changes in occurrence of capsular serotypes of Streptococcus pneumoniae at Boston City Hospital during selected years between 1935 and 1974, J. Clin. Microbiol. 5:154–166 (1977).PubMedGoogle Scholar
  54. 53.
    Finland, M. and Barnes M. W. , Acute bacterial meningitis at Boston City Hospital during 12 selected years, 1935–1972, J. Infect. Dis. 136:400–415 (1977).PubMedGoogle Scholar
  55. 54.
    Finland, M., and Barnes, M. W., Changing ecology of acute bacterial empyema: Occurrence and mortality at Boston City Hospital during twelve selected years from 1935 to 1972, J. Infect. Dis. 157:274–291 (1978).Google Scholar
  56. 55.
    Finland, M., and Sutliff, W. D., Specific cutaneous reactions and circulating antibodies in the course of lobar pneumonia. I. Cases receiving no serum therapy, J. Exp. Med. 54:637–652 (1931).PubMedGoogle Scholar
  57. 56.
    Finland, M., and Sutliff, W. D., Specific antibody response of human subjects to intracutaneous injection of pneumococcus products, J. Exp. Med. 55:853–865 (1932).PubMedGoogle Scholar
  58. 57.
    Finland, M., and Tilghman, R. C., Bacteriological and immunological studies in families with pneumococcic infections: The development of type-specific antibodies in healthy contact carriers, J. Clin. Invest. 15:501–508 (1936).PubMedGoogle Scholar
  59. 58.
    Finland, M., and Winkler, A. W., Recurrences in pneumococcus pneumonia, Am. J. Med. Sci. 188:309–320 (1934).Google Scholar
  60. 59.
    Giebink, G. S. , The pathogenesis of otitis media in chinchillas and the efficacy of vaccination on prophylaxis, Rev. Infect. Dis. 3:342–352 (1981).PubMedGoogle Scholar
  61. 60.
    Giebink, G. S. , Preventing pneumococcal disease in children: Recommendations for using pneumococcal vaccine, Pediatr. Infect. Dis. 4:343–348 (1985).PubMedGoogle Scholar
  62. 61.
    Giebink, G. S., Grebner, J. V., Kim, Y., and Quie, P. G., Severe opsonic deficiency produced by Streptococcus pneumoniae and by capsular polysaccharide antigens, Yale J. Biol. Med. 51:527–538 (1978).PubMedGoogle Scholar
  63. 62.
    Giebink, G. S., Schiffman G., Krivit, W., and Quie, P. G. , Vaccine-type pneumococcal pneumonia after vaccination in an asplenic patient, J. Am. Med. Assoc. 241:2736–2737 (1979).Google Scholar
  64. 63.
    Giebink, G. S., Berzins, J. K., Marker, S. C., and Schiffman, G., Experimental otitis media after nasal inoculation of Streptococcus pneumoniae and influenza A in chinchillas, Infect. Immun. 30:445–450 (1980).PubMedGoogle Scholar
  65. 64.
    Giebink, G. S., Le, C. T., Cosio, F. G., Spika, J. S., and Schiffman, G., Serum antibody responses of high-’risk children and adults to vaccination with capsular polysaccharides of Streptococcus pneumoniae, Rev. Infect. Dis. 3(Suppl.): S168-S178 (1981).Google Scholar
  66. 65.
    Gilman, B. B. , and Anderson G. W., Community outbreak of type I pneumococcus infection, Am. J. Hyg. 28:345–358 (1938).Google Scholar
  67. 66.
    Goodner, K. , Development and localization of dermal pneumococcic infection in the rabbit, J. Exp. Med. 54:847–858 (1931).PubMedGoogle Scholar
  68. 67.
    Gorgas, W. C., Sanitation on the Panama Canal, J. Am. Med. Assoc. 40:953–955 (1913).Google Scholar
  69. 68.
    Greenberg, D., Relation of meteorological conditions to the prevalence of pneumonia, J. Am. Med. Assoc. 72:252–257 (1919).Google Scholar
  70. 69.
    Greenwood, M., Newbold, E. M., Topley, W. N. , and Wilson, J., On the mechanism of protection against infectious disease, J. Hyg. 28:117–132 (1928).Google Scholar
  71. 70.
    Handwerger, S. , and Tomasz, A. , Alterations in penicillin-binding proteins of clinical and laboratory isolates of pathogenic Streptococcus pneumoniae with low levels of penicillin resistance, J. Infect. Dis. 153:83–89 (1986).PubMedGoogle Scholar
  72. 71.
    Hansman, D. , and Bullen, M. M., A resistant pneumococcus, Lancet 2:264–265 (1967).Google Scholar
  73. 72.
    Harris, A. H., and Ingraham, H. S., Study of carrier condition associated with type II pneumonia in camp of Civilian Conservation Corps, J. Clin. Invest. 16:41–48 (1937).PubMedGoogle Scholar
  74. 73.
    Health and Public Policy Committee, American College of Physicians, Pneumococcal vaccine, Ann. Intern. Med. 104:118–120 (1986).Google Scholar
  75. 74.
    Heffron, R. , Pneumonia with Special Reference to Pneumococcus Lobar Pneumonia, p. 268, Commonwealth Fund, New York, 1939; reprinted by Harvard University Press (1979).Google Scholar
  76. 75.
    Hirsch, E. F. , and Mckinney, M., An epidemic of pneumococcus bronchopneumonia, J. Infect. Dis. 24:594–617 (1919).Google Scholar
  77. 76.
    Holle, H. A., and Bullowa, J. G. M., Pneumococcal cross-infections in home and hospital, N. Engl. J. Med. 223:887–890 (1940).Google Scholar
  78. 77.
    Ivemark, B., Implications of agenesis of the spleen on the pathogenesis of conotruncal anomalies in children, Acta Pediatr. Scand. (Suppl. 104) 44:590 (1955).Google Scholar
  79. 78.
    Jacobs, M. R., Koornhof, H. J., Robins-Brown, R. M., Stevenson, C. M., Vermaak, Z. A., Freiman, I., Miller, G. B. , Witcomb, M. A., Isaäcson, M. , Ward, J. I. , and Austrian, R. , Emergence of multiply resistant pneumococci, N. Engl. J. Med. 299:735–740 (1978).PubMedGoogle Scholar
  80. 79.
    Johnston, H., Pneumonia as contagious disease, Can. Med. Assoc. J. 38:270–271 (1938).Google Scholar
  81. 80.
    Kass, E. H. (ed.), Assessment of the pneumococcal polysaccharide vaccine: A workshop held at the Harvard Club of Boston, Boston, Massachusetts, October 6, 1980, Rev. Infect. Dis. 3(Suppl .): S1-S197 (1981).Google Scholar
  82. 81.
    Kass, E. H., Green, G. M., and Goldstein, E., Mechanism of antibacterial action in the respiratory tract, Bacteriol. Rev. 30:488–496 (1966).PubMedGoogle Scholar
  83. 82.
    Kaufman, P., Pneumonia in old age. Active immunization against pneumonia with pneumococcus polysaccharides; results of a six year study, Arch. Intern. Med. 79:518–531 (1947).Google Scholar
  84. 83.
    Klein, J. O., The epidemiology of pneumococcal disease in infants and children, Rev. Infect. Dis. 3:246–253 (1981).PubMedGoogle Scholar
  85. 84.
    Laforce, F. M., and Eickhoff, T. C., Pneumococcal vaccine: The evidence mounts, Ann. Intern. Med. 104:110–112 (1986).PubMedGoogle Scholar
  86. 85.
    Lazarus, H. M. , Lederman, M. , Lubin, A., Herzig, R. H., Schiffman, G., Jones, P. , Wine, A. , and Rodman, H. M. , Pneumococcal vaccination: The response of patients with multiple myeloma, Am. J. Med. 69:419–423 (1980).PubMedGoogle Scholar
  87. 86.
    Lee, C.-J., Fraser, B. A., Szu, S., and Lin, K.-T., Chemical structure of and immune response to polysaccharides of Streptococcus pneumoniae, Rev. Infect. Dis. 3:323–331 (1981).PubMedGoogle Scholar
  88. 87.
    Lin, K.-T., and Lee, C.-J., Immune response of neonates to pneumococcal polysaccharide-protein conjugate, Immunology 46:333–342 (1982).PubMedGoogle Scholar
  89. 88.
    Lister, F. S., Specific serological reactions with pneumococci from different sources, Publ. S. Afr. Inst. Med. Res. 1:1–14 (1913).Google Scholar
  90. 89.
    Lister, F. S. , An experimental study of prophylactic inoculation against pneumococcal infection in the rabbit and in man, Publ. S. Afr. Inst. Med. Res. 1:231–287 (1916).Google Scholar
  91. 90.
    Lister, F. S. , Prophylactic inoculation of man against pneumococcal infections, and more particularly against lobar pneumonia, Publ. S. Afr. Inst. Med. Res. 10:304–322 (1917).Google Scholar
  92. 91.
    Lister, S. , and Ordman, D. , Epidemiology of pneumonia on the Witwatersrand goldfields and prevention of pneumonia and other acute respiratory diseases in native laborers in South Africa by means of vaccine, Publ. S. Afr. Inst. Med. Res. 7:1–124 (1935).Google Scholar
  93. 92.
    Lowell, F. C. , Strauss, E. , and Finland, M. , Observations on the susceptibility of pneumococci to sulfapyridine, sulfathiazole and sulfamethoxazole, Ann. Intern. Med. 14:1001–1023 (1940).Google Scholar
  94. 93.
    Lund, E., Types of pneumococci found in blood, spinal fluid and pleural exudate during 15 years (1954–1969), Acta Pathol. Microbiol. Scand. Sect. B 78:333–336 (1970).Google Scholar
  95. 94.
    Lund, E., Pulverer, G., and Jeljaszewicz, J., Serological types of Diplococcus pneumoniae strains isolated in Germany, Med. Microbiol. Immunol. 159:171–178 (1974).Google Scholar
  96. 95.
    Macleod, C. M. , Hodges, R. G., Heidelberger, M., and Bernhard, W. G., Prevention of pneumococcal pneumonia by immunization with specific capsular polysaccharides, J. Exp. Med. 82:445–465 (1945).Google Scholar
  97. 96.
    Maynard, G. D. , An enquiry into the etiology, manifestations and prevention of pneumonia amongst natives on the Rand from tropical areas, Publ. S. Afr. Inst. Med. Res. 1:1–101 (1913).Google Scholar
  98. 97.
    Mcgowan, J. E. Jr. , Bratton, L. , Klein, J. O. and Finland, M. , Bacteremia in febrile children in a “walk-in” pediatric clinic, N. Engl. J. Med. 288:1309–1312 (1973).PubMedGoogle Scholar
  99. 98.
    McGowan, J. E., Jr. , Barnes, M. W. , and Finland, M., Bacteremia at Boston City Hospital: Occurrence and mortality during 12 selected years 1935–1972, with special reference to hospital-acquired cases, J. Infect. Dis. 132:316–335 (1975).PubMedGoogle Scholar
  100. 99.
    Moore, H. F. , and Chesney, A. M. , A further study of ethyl-hydrocupreine (optochin) in the treatment of acute lobar pneumonia, Arch. Intern. Med. 21:659–681 (1918).Google Scholar
  101. 100.
    Mufson, M. A., Pneumococcal infections, J. Am. Med. Assoc. 246:1942–1948 (1981).Google Scholar
  102. 101.
    Nemir, R. L. , Andrews, E. T. , and Vinograd, J., Pneumonia in infants and children: Bacteriologic study with special reference to clinical significance, Am. J. Dis. Child. 51:1277–1295 (1936).Google Scholar
  103. 102.
    Netter, Contagion de la pneumonie, Arch. Gen. Med. (Paris) 21:530–544, (1888).Google Scholar
  104. 102a.
    Netter, Contagion de la pneumonie, Arch. Gen. Med. (Paris) 21:699–718, (1888).Google Scholar
  105. 102b.
    Netter, Contagion de la pneumonie, Arch. Gen. Med. (Paris) 22:42–59, (1888).Google Scholar
  106. 103.
    Neufeld, F. , Ueber eine specifische bakteriolytische Wirkung der Galle, Z. Hyg. Infektionskr. 34:454–464 (1900).Google Scholar
  107. 104.
    Neufeld, F. , Ueber die Agglutination der Pneumokokken und Ueber die Theorien der Agglutination, Z. Hyg. Infektionskr. 40:54–72 (1902).Google Scholar
  108. 105.
    Opie, E. L. , Blake, F. G. , Small, J. C. , and Rivers, T. M. , Epidemic Respiratory Disease: The Pneumonias and Other Infections of the Respiratory Tract Accompanying Influenza and Measles, Mosby, St. Louis, 1921.Google Scholar
  109. 106.
    Ordman, D. , Pneumonia in the native mine workers of the Witwatersrand goldfields: A bacteriological and epidemiological study, J. Med. Assoc. S. Afr. 5:108–116 (1931).Google Scholar
  110. 107.
    Ordman, D., Pneumonia in the native mine labourers of northern Rhodesia copperfields with an account of an experiment in pneumonia prophylaxis by means of a vaccine at the Roan Antelope Mine, Publ. S. Afri. Inst. Med. Res. 7:1–124 (1935).Google Scholar
  111. 108.
    Ordman, D. , Pneumococcus typing: Its value in pneumonia, S. Afr. Med. J. 11:569–573 (1937).Google Scholar
  112. 109.
    Ordman, D. , Pneumococcus types in South Africa: A study of their occurrence and the effect thereon of prophylactic inoculation, Publ. S. Afr. Inst. Med. Res. 9:1–27 (1938).Google Scholar
  113. 110.
    Orenstein, A. J. , Vaccine prophylaxis in pneumonia: A review of fourteen years’ experience with inoculation of native mine workers on the Witwatersrand against pneumonia, J. Med. Assoc. S. Afr. 5:339–346 (1931).Google Scholar
  114. 111.
    Pallares, R. , Gudiol, F. , Linares, J., Ariza, J. , Rufi, G. , Murgui, L. , Dorca, J. , and Viladrich, P. F. , Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci, N. Engl. J. Med. 317:18–22 (1987).PubMedGoogle Scholar
  115. 112.
    Park, J. H., Jr. , and Chickering, H. T. , Type I pneumococcal lobar pneumonia among Puerto Rican laborers of Camp Jackson, South Carolina, J. Am. Med. Assoc. 73:183–186 (1919).Google Scholar
  116. 113.
    Parker, M. T. , Type distribution of pneumococci isolated from serious diseases in Britain, in: Pathogenic Streptococci (M. T. Parker, ed.), pp. 191–192, Redbooks, Chertsey, England, 1979.Google Scholar
  117. 114.
    Patrick, K. M. , and Woolley, F. R. , A cost-benefit analysis of immunization of pneumococcal pneumonia, J. Am. Med. Assoc. 245:473–477 (1981).Google Scholar
  118. 115.
    Pearson, H. A. , Splenectomy: Its risks and its roles, Hosp. Pract. August: 85–94 (1980).Google Scholar
  119. 116.
    Perlino, C. A., and Rimland, D., Alcoholism leukopenia and pneumococcal sepsis, Am. Rev. Respir. Dis. 132:757–760 (1985).PubMedGoogle Scholar
  120. 117.
    Quie, P. G., Giebink, G. S., and Winkelstein, J. A. (guest eds.), The Pneumoncoccus: A symposium held at the Kroc Foundation Headquarters, Santa Ynez Valley, California, February 25–29, 1980.Google Scholar
  121. 117a.
    Quie, P. G., Giebink, G. S., and Winkelstein, J. A. Rev. Infect. Dis. 3:183–371 (1981).Google Scholar
  122. 118.
    Recommendation of the Public Health Service Advisory Committee on Immunization Practices: Pneumococcal polysaccharide vaccine, Morbid. Mortal. Weekly Rep. 27:25–31 (1978).Google Scholar
  123. 119.
    Riley, I. D. , and Douglas, R. M., An epidemiologic approach to pneumococcal disease, Rev. Infect. Dis. 3:233–245 (1981).PubMedGoogle Scholar
  124. 120.
    Robbins, J. B. , Austrian, R., Lee, C.-J., Rastogi, S. C., Schiffman, G., Henrichsen, J. , Makela, P. H., Broome, C. V. , Facklam, R. R. , Tiesjema, R. H. , and Parke, J. C.,Jr., Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphases on the cross-reactive types within groups, J. Infect. Dis. 148:1136–1159 (1983).PubMedGoogle Scholar
  125. 121.
    Robertson, O. H. , Instance of lobar pneumonia acquired in the laboratory, J. Prey. Med. 5:221–224 (1931).Google Scholar
  126. 122.
    Rogers, L. , Relationship between pneumonia incidence and climate in India, Lancet 1:1173–1177 (1925).Google Scholar
  127. 123.
    Rytel, M. W. , Pneumococcal pneumonia, in: Rapid Diagnosis in Infectious Disease (M. W. Rytel, ed.), pp. 91–103, CRC Press, Boca Raton, 1979.Google Scholar
  128. 124.
    Rytel, M. W. , Dee, T. H. , Ferstenfeld, J. E. , and Hensley, G. T., Possible pathogenic role of capsular antigens in fulminant pneumococcal disease with disseminated intravascular coagulation, Am. J. Med. 57:889–896 (1974).PubMedGoogle Scholar
  129. 125.
    Saah, A. J. , Mallonee, J. R. , Tarpay, M. , Thornsberry, C. T. , Roberts, M. A., and Rhoades, E. R. , Relative resistance to penicillin in the pneumococcus, J. Am. Med. Assoc. 243:1824–1827 (1980).Google Scholar
  130. 126.
    Sabin, A. B. , “Stained slide” microscopic agglutination test: Application to (1) rapid typing of pneumococci, (2) determination of antibody, Am. J. Public Health 19:1148–1150 (1929).Google Scholar
  131. 127.
    Sabin, A. B., Immediate pneumococcus typing directly from sputum by the Neufeld reaction, J. Am. Med. Assoc. 100:1584–1586 (1933).Google Scholar
  132. 128.
    Schiffman, G., Immune response to pneumococcal polysaccharide antigens: A comparison of the murine model and the response in humans, Rev. Infect. Dis. 3:224–231 (1981).PubMedGoogle Scholar
  133. 129.
    Schiffman, G. , Douglas, R. M. , Bonner, M. J. , Robbins, M. , and Austrian, R. , A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. 1. Methods for the radioimmunoassay of anticapsular antibodies and comparison of other techniques, J. Immunol. Methods 33:133–144 (1980).PubMedGoogle Scholar
  134. 130.
    Schneerson, R. , Robbins, J. B. , Chu, C., Sutton, A., Vann, W. , Vickers, J. C., London, W. T. , Curfman, B., Hardegree, M. C., Shiloach, J., and Rastogi, S. C., Serum antibody responses of juvenile and infant rhesus monkeys injected with Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-protein conjugates, Infect. Immun. 45:582–591 (1984).PubMedGoogle Scholar
  135. 131.
    Schwartz, J. S., Pneumococcal vaccine: Clinical efficacy and effectiveness, Ann. Intern. Med. 96:208–220 (1982).PubMedGoogle Scholar
  136. 132.
    Sell, S. H. , Wright, P. F. , Vaughan, W. K., Thompson, J. , and Schiffman, G. , Clinical studies of pneumococcal vaccine in infants. 1. Reactogenicity and immunogenicity of two polyvalent polysaccharide vaccines, Rev. Infect. Dis. 3:S97-S107 (1981).Google Scholar
  137. 133.
    Shapiro, E. D. , Pneumococcal vaccine failure [letter], N. Engl. J. Med. 316:1272–1273 (1987).Google Scholar
  138. 134.
    Shapiro, E. D., and Clemens, J. D., A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk for serious pneumococcal infections, Ann. Intern. Med. 101:325–330 (1984).PubMedGoogle Scholar
  139. 135.
    Siber, G., Immunoprophylaxis and therapy of Haemophilus influenzae and pneumococcal infections, Program and Abstracts of the Twenty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, p. 63, American Society for Microbiology, Washington, D.C., 1987.Google Scholar
  140. 136.
    Simberkoff, M. S. , Richmond, A., Lukaszewski, M., Cross, A. P. , Baltch, A. , Nadler, J., Al-Ibrahim, M., and Geisler, P. J., Isolation of multiply antibiotic-resistant pneumococci, New York, Morbid. Mortal. Weekly Rep. 34:545–546 (1985).Google Scholar
  141. 137.
    Simberkoff, M. S. , Cross, A. P. , Al-Ibrahim, M., Baltch, A. L. , Geisler, P. J. , Nadler, J. , Richmond, A. S. , Smith, R. P. , and Van Eeckhout, J. P. , Efficacy of pneumococcal vaccine in high-risk patients: Results of a Veterans Administration cooperative study, N. Engl. J. Med. 315:1318–1327 (1986).PubMedGoogle Scholar
  142. 138.
    Simberkoff, M. S. , Lukaszewski, M., Cross, A. , Alibrahim, M., Baltch, A. L., Smith, R. P., Geisler, P. J., Nadler, J. , and Richmond, A. S. , Antibiotic isolates of Streptococcus pneumoniae from clinical specimens: A cluster of serotype 19A organisms in Brooklyn, New York, J. Infect. Dis. 153:78–82 (1986).PubMedGoogle Scholar
  143. 139.
    Sisk, J. E. , and Riegelman, R. K. , Cost effectiveness of vaccination against pneumococcal pneumonia: An update, Ann. Intern. Med. 104:79–86 (1986).PubMedGoogle Scholar
  144. 140.
    Small, A. A., Pneumonia at a base hospital: Observations in one thousand and one hundred cases at Camp Pike, Ark. , J. Am. Med. Assoc. 71:700–702 (1918).Google Scholar
  145. 141.
    Smillie, W. E., Study of an outbreak of type Ii pneumococcus pneumonia in Veterans’ Administration Hospital at Bedford, Massachusetts, Am. J. Hyg. 24:522–535 (1936).Google Scholar
  146. 142.
    Smillie, W. E., Warnock, G. H., and White, H. J., Study of a type I pneumococcus epidemic at the State Hospital at Worcester, Mass., Am. J. Public Health 28:293–302 (1938).Google Scholar
  147. 143.
    Smit, P. , Oberholzer, D., Hayden-Smith, S. , Koornhof, H. J., and Hilleman, M. R., Protective efficacy of pneumococcal polysaccharide vaccines, J. Am. Med. Assoc. 238:2613–2616 (1977).Google Scholar
  148. 144.
    Stillman, E. G., Susceptibility of rabbits to infection by the inhalation of type Ii pneumococcus, J. Exp. Med. 52:215–224 (1930).PubMedGoogle Scholar
  149. 145.
    Stillman, E. G., and Branch, A., Experimental production of pneumococcus pneumonia in mice by inhalation method, J. Exp. Med. 40:733–742 (1924).PubMedGoogle Scholar
  150. 146.
    Strauss, E. , and Finland, M., Further studies on recurrences in pneumococcic pneumonia with special reference to the effect of specific treatment, Ann. Intern. Med. 16:17–32 (1942).Google Scholar
  151. 147.
    Sydenstricker, V. P. W., and Sutton, A. C., An epidemiological study of lobar pneumonia, Bull. Johns Hopkins Hosp. 38:312–315 (1918).Google Scholar
  152. 148.
    Teele, D. W., Pelton, S. I., Grant, M. J. A., Herskowitz, J., Rosen, D. J., Allen, C. E., Wimer, R. S. , and Klein, J. O., Bacteremia in febrile children under 2 years of age: Results of cultures of blood in 600 consecutive febrile children in a “walk-in” clinic, J. Pediatr. 87:227–230 (1975).PubMedGoogle Scholar
  153. 149.
    Tenny, C. F. , and Rivenburgh, W. T. , A group of 68 cases of type I pneumonia occurring in 30 days at Camp Upton, Arch. Intern. Med. 24:545–552 (1919).Google Scholar
  154. 150.
    Terrell, E. E. , Robertson, O. H., and Coggeshall, L. T. , Experimental pneumococcus lobar pneumonia in the dog. I. Method of production and course of disease, J. Clin. Invest. 12:393–432 (1933).PubMedGoogle Scholar
  155. 151.
    Tilghman, R. C. , and Finland, M. , Clinical significance of bacteremia in pneumococcal pneumonia, Arch. Intern. Med. 59:602–619 (1937).Google Scholar
  156. 152.
    Tillotson, J. R. , and Finland, M. , Bacterial colonization and clinical superinfection of the respiratory tract complicating antibiotic treatment of pneumonia, J. Infect. Dis. 119:597–624 (1969).PubMedGoogle Scholar
  157. 153.
    Tomasz, A., Surface components of Streptococcus pneumoniae, Rev. Infect. Dis. 3:190–211 (1981).Google Scholar
  158. 154.
    Tomforde, Eine Endemie von croupöser Pneumonie im Dorfe Laumuhlen, Kreis Neuhaus an der Oste, Januar 1902, Dtsch, Med. Wochenschr. 28:577–579 (1902).Google Scholar
  159. 155.
    U.S. Congress, Office of Technology Assessment, A Review of Selected Federal Vaccine and Immunization Policies, U.S. Government Printing Office, Washington, D.C., 1979.Google Scholar
  160. 156.
    Verhoef, J., Effects of nutrition on antibiotic action, in: Action of Antibiotics in Patients (L. D. Sabath and G. G. Grassi, eds.), Huber, Bern, 1982.Google Scholar
  161. 157.
    Waldman, J. D., Rosenthal, A., Smith, A. L. , Shurin, S. , and Nadas, A. S. , Sepsis and congenital asplenia, J. Pediatr. 90:555–559 (1977).PubMedGoogle Scholar
  162. 158.
    Wara, D. W., Host defense against Streptococcus pneumoniae: The role of the spleen, Rev. Infect. Dis. 3:299–309 (1981).PubMedGoogle Scholar
  163. 159.
    Ward, J., Antibiotic-resistant Streptococcus pneumoniae: Clinical and epidemiologic aspects, Rev. Infect. Dis. 3:254–266 (1981).PubMedGoogle Scholar
  164. 160.
    Webster, L. T. , Mode of spread of Friedlander’s bacilluslike respiratory infection in mice, J. Exp. Med. 47:685–712 (1928).PubMedGoogle Scholar
  165. 161.
    Whitby, L. , Chemotherapy of bacterial infections (Bradshaw Lecture), Lancet 2:1095–1103 (1938).Google Scholar
  166. 162.
    White, B. (with the collaboration of Robinson, E. S., and Barnes, L. A.), The Biology ofPneumococcus: The Bacteriological, Biochemical and Immunological Characters and Activities of Diplococcus pneumoniae, Commonwealth Fund, New York, 1938; reprinted by Harvard University Press (1979).Google Scholar
  167. 163.
    Winkelstein, J. A., The role of complement in the hosts’ defense against Streptococcus pneumoniae, Rev. Infect. Dis. 3:289–298 (1981).Google Scholar
  168. 164.
    Wood, C. C., McNamara, J. G., Schwarz, D. F., Merrill, W. W., and Shapiro, E. D., Prevention of pneumococcal bacteremia in a child with Aids-related complex, Pediatr. Infect. Dis. J. 6:564–566 (1987).PubMedGoogle Scholar
  169. 165.
    Wright, A. E. , Morgan, W. , Colbrook, L. , and Dodgson, R. W., Observations on prophylactic inoculations against pneumococcus infection, and on the results which have been achieved by it, Lancet 1:1–10, 87–95 (1914).Google Scholar
  170. 166.
    Zighelboim, S., and Tomasz, A., Multiple antibiotic resistance in South African strains of Streptococcus pneumoniae: Mechanism of resistance to β-lactam antibiotics, Rev. Infect. Dis. 3:267–276 (1981).PubMedGoogle Scholar

Suggested Reading

  1. Applebaum, P. R. World-wide development of antibiotic resistance in pneumococci, Eur. J. Clin. Microbiol. 6:367–377, 1987 (131 refs.).Google Scholar
  2. Finland, M. , Recent advances in the epidemiology of pneumococcal infections, Medicine 21:307–344 1942 (332 refs.).Google Scholar
  3. Heffron, R. , Pneumonia with Special Reference to Pneumococcal Lobar Pneumonia, Commonwealth Fund, New York, 1939; reprinted by Harvard University Press, 1979 (1471 refs.).Google Scholar
  4. Kass, E. H. (ed.), Assessment of the pneumococcal polysaccharide vaccine: A workshop held at the Harvard Club of Boston, Boston, Massachusetts, October 6, 1980, Rev. Infect. Dis. 3 (Suppl.): S1-S197, 1981 (213 refs.).Google Scholar
  5. Mufson, M. A. , Pneumococcal infections, J. Am. Med. Assoc. 246:1942–1948 1981 (132 refs.).Google Scholar
  6. Quie, P. G., Giebink, G. S., and Winkelstein, J. A. (guest eds.), The Pneumococcus: A symposium held at the Kroc Foundation Headquarters, Santa Ynez Valley, California, February 25–29, 1980, Rev. Infect. Dis. 3:183–371 (1981) (197 refs.).Google Scholar
  7. White, B. (with the collaboration of Robinson, E. S. , and Barnes, L. A.), The Biology of Pneumococcus: The Bacteriological, Biochemical and Immunological Characters and Activities of Diplococcus pneumoniae, Commonwealth Fund, New York, 1938; reprinted by Harvard University Press, 1979 (1593 refs.).Google Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Robert S. Baltimore
    • 1
  • Eugene D. Shapiro
    • 1
  1. 1.Departments of Pediatrics and Epidemiology and Public HealthYale University School of MedicineNew HavenUSA

Personalised recommendations